Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Apr 11;15:40. doi: 10.1186/s12886-015-0025-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Batioglu et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Visual and anatomical improvement after 3 aflibercept injections in a ranibizumab resistant AMD case. a. Large-septa cysts are seen on OCT following 11 ranibizumab injections (VA: 1.3 LogMAR). b: The cysts have completely disappeared after a single aflibercept injection (VA: 0.7 LogMAR). c. There is no cyst on OCT and VA has been increased after the third aflibercept injection (VA:0.4 LogMAR). AMD: Age-related macular degeneration. PED: Pigment epithelial detachment. VA: Visual acuity. OCT: Optic coherence tomography.